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ABSTRACT 
Losartan is high specific angiotensin 2 type receptor antagonist with antihypertensive activity was formulated as microspheres by using Ethyl 
cellulose as carrier. These Ethyl cellulose microspheres were prepared by the solvent evaporation method. The prepared microspheres were 
subjected to various evaluation and in vitro release studies. Highest percentage of loading was obtained by increasing the amount of Losartan with 
respect to polymer. The particle sizes of the prepared microspheres were determined by optical microscopy and SEM analysis. The prepared 
microspheres had good spherical geometry with smooth surface as evidence by SEM. The in vitro release studies showed that Losartan 
microspheres of 1:5 ratios showed better sustained effect over a period of 12 hours. 
Keywords: Ethylcellulose microspheres, Solvent evaporation, Losartan. 
 
INTRODUCTION 
Microspheres are carriers for Control Release and can be defined as 
solid spherical monolithic free flowing particles having size range 
between 1-1000 micrometres; typical size is 1-500 micrometres. 
Microspheres are used to sustain the release of drug and for 
localized effect. They also give protection to the drug from chemical 
and enzymatic degradation. In addition they reduce toxicity and 
improves therapeutic efficacy of drug and for localized effect.  
Losartan potassium is a highly specific angiotensin 2 type receptor 
antagonist with antihypertensive activity. The drug is readily 
absorbed from the GI tract, following oral administration. It has 
significant first pass metabolism hence its bio availability is 25-35.  
Since the drug has low elimination half life (i.e. 1.5-2 hrs), it is 
suitable candidate for oral controlled release. Administration of 
Losartan in a controlled release dosage form with an extended 
release over 8 h, would be more desirable as these characteristics 
would allow a rapid onset followed by protracted anti-hypertensive 
effects by maintaining the plasma concentration of the drug well 
above the therapeutic concentration. The daily dose of Losartan is 
25- 100 mg. However, it still has significant side-effects like 
dizziness, constipation, fatigue and headache; these side effects can 
be minimized by fabricating a sustain release dosage form. Losartan 
has short biological half-life (1.5 to 2 hours) and it is rapidly 
eliminated from the body[1,2]. Hence there is a need to develop a 
system which provides control release of drug.  The objective of 
present investigation is to prepare Losartan microspheres by using 
solvent evaporation method Microspheres were prepared by using 
Ethyl cellulose in various drug and polymer ratios (1:2, 1:3, 1:4). 
Various physicochemical characteristics and in vitro release rates 
from these microspheres were then examined.  
MATERIALS AND METHODS 
Losartan Potassium was received as a gift sample from Aurabindo 
Pharma Pvt.Ltd, Hyderabad. Ethyl cellulose was purchased from 
Loba chemicals Pvt. Ltd. Liquid paraffin and Span 80 were purchased 
from Finar chemical, Ahmadabad and all other ingredients used 
were of analytical standard.  
Preparation of Losartan Potassium microspheres by using 
solvent evaporation method 
The drug and polymer in different proportions (1:2, 1:3, 1:4, 1:5 and 
1:6) were weighed & dissolved at room temperature into Methanol 
with vigorous agitation to form uniform drug polymer dispersion. 
This was slowly poured into the dispersion medium consisting of 
light liquid paraffin (200 ml) containing 0.1% Span 80.  
The system was stirred using 3 blade homogenizer at 500 rpm, at 
room temperature over a period of 2-3 hours, to ensure complete 
evaporation of the solvent. The liquid paraffin was then decanted & 
the microspheres were separated by filtration through a Whatmann 
filter paper, washed thrice with 180 ml of n- hexane and air dried for 
24 hours[3,4]. Five batches of microspheres were prepared & 
labelled as F1, F2, F3, F4 and F5. 
 
Table 1: Drug and polymer ratio of losartan potassium loaded 












F1 1:2 100 200 
F2 1:3 100 300 
F3 1:4 100 400 
F4 1:5 100 500 
F5 1:6 100 600 
 
Evaluation of microspheres 
Particle size measurement 
The microspheres size was determined by the optical microscopy 
method using a calibrated stage micrometer (μm) and the size of 
particle was calculated by using equation[5].  
 
Percentage yield 
Percentage practical yield is calculated to understand the efficiency 
of any method, as it helps in selection of appropriate method of 
production. Practical yield was calculated as the weight of LP 
microspheres obtained from each batch in relation to the amount of 
drug and polymer used in the preparation [6].  
Percentage yield was calculated using the formula: 
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% Yield = Weight of microspheres obtained after solvent evaporation
Amount of drug and polymer used
× 100 … 
(Eq. 2) 
Encapsulation efficiency 
Drug loaded microspheres (100 mg) were powdered and suspended 
in 100 ml methanolic: water (5:95 v/v) solvent. The resultant 
dispersion was kept for 20 min for complete mixing with continuous 
agitation using magnetic stirrer and filtered using a wattmann filter. 
The drug content was determined spectrophotometrically at 234 nm 
using a regression equation derived from the standard graph 
(r2
Encapsulation Efficiency = Practical Drug content
Theoretical Drug content
× 10   …(Eq. 3) 
=0.998) [7]. 
Effect of drug-polymer ratio on particle size, %yield and %EEof 
Losartan Potassium Loaded Microspheres 
For this study five different batches were prepared. The particle size 
was measured and %yield and %EE were studied by increasing the 
polymer. Depending on parameters particle size and drug release 
the optimized ratio (formulation) was selected.  
I. R. Spectroscopy 
IR spectroscopy was carried out to check the compatibility between 
drug and polymers. The IR spectra of drug with polymer were 
compared with the standard I.R. spectrum of the pure drug [8]. 
Surface Morphology (SEM) 
Scanning electron microscopy was used to determine particle size 
distribution, surface topography, texture, and to examine the 
morphology of fractured or sectioned surface. SEM is the most 
commonly used method for characterizing drug delivery systems, 
owing in large to simplicity of sample preparation and ease of 
operation.  
SEM studies were carried out by using JEOL JSM T-330A scanning 
microscope (Japan). Dry LP microspheres were placed on an electron 
microscope brass stub and coated with in an ion sputter. Picture of LP 
microspheres were taken by random scanning of the stub. 
In vitro drug release studies 
The drug dissolution tests of microspheres were carried out in pH 
6.8 Phosphate buffer 900ml in the rotating basket method 
specified in the US Pharmacopoeia. Microspheres were weighed 
(weight equivalent to 50 mg of drug) and filled in capsules then 
these microspheres were placed in the basket of dissolution 
medium with rotation speed of 100 rpm and thermostatically 
controlled at 37o
RESULTS AND DISCUSSIONS 
C. Perfect sink conditions were maintained during 
the dissolution tests. The sample solution was withdrawn at a 
suitable interval from the dissolution vessel and analysed 
spetrophotometrically at 234 nm[9]. 
Particle size measurement 
The particle size analysis was carried out using optical microscope 
for all the five formulations. F1 showed the smallest particle size and 
highest Particle size was observed in F5 formulation. The average 
particle size was observed between 18 to 86 µm. (Table 2) 
 
Table 2: Particle Size Measurement of Losartan Potassium 












1 F1 14.23 - 24.8 18.04 ±2.43 
2 F2 31.43 - 34.65 32.33 ±3.03 
3 F3 53.24 - 58.67 56.45 ±1.82 
4 F4 63.18 - 69.91 68.15 ±1.60 
5 F5 84.24 - 88.42 86. 83 ±3.61 
Percentage Yield  
The percentage yield of microspheres of Losartan Potassium using 
Ethyl cellulose ranged from 89% to 96%. 
Encapsulation Efficiency 
The amount of drug encapsulated in the microspheres gives an 
estimate of encapsulation efficiency which is an important 
parameter in the selection of microspheres for further 
characterization. Three batches for each formulation were prepared, 
among the different formulations, one best formulation was selected 
on the basis of in vitro drug release and the concentration of Span80 
of this formulation was further changed to see the effect on 
encapsulation. Maximum encapsulation of 91% was observed in F5, 
followed by 88% in F4, 85%in F3, 78% in F2 and 73%in F1. The 
encapsulation efficiency of the five formulations is in the following 
order F5 > F4 > F3 > F2 > F1. Hence it was observed that as the 
weight of the polymer increased, there was an increase in the 
encapsulation efficiency. 
Effect of drug-polymer ratio on particle size, % yield and %EE 
Effect of drug-polymer ratio on particle size, % yield and % EE was 
studied. As the polymer ratio increased the particle size, % yield and 
% EE also increased. Results were shown in the (Table 3).  
 
Table 3: Effect of drug-polymer ratio on particle size, %yield, 












1 1:2 200 500 89.99±1.37 73.15±1.28 
2 1:3 200 500 90.25±1.80 78.54±0.59 
3 1:4 200 500 94.50±2.18 85.12±1.31 
4 1:5 200 500 95.39±2.30 88.31±0.78 
5 1:6 200 500 96.33±0.69 91.32±2.92 
 
I.R. Spectroscopy 
FT-IR spectra of pure Losartan Potassium, Ethyl Cellulose were 
recorded on Perkin Elmer spectrophotometer. The scans were 
evaluated for presence of principal peaks of drug, shifting and 
masking of drug peaks due to presence of polymer. No significant 
change in peaks was observed hence there are no drug and polymer 
interactions. 
Surface morphology of Losartan potassium microspheres (SEM) 
The surface morphology of the LP microspheres was studied by SEM. 
SEM photograph of the Formulation F5 was shown in the Fig1. 
Surface smoothness of the LP microspheres was increased with the 
increase in the polymer concentration, which was confirmed by 
SEM. At lower polymer conc. (1:2) surface was rough and crumpled 
and at higher polymer conc. (1:6) the LP microspheres with smooth 
surface were obtained 
 
 
Fig.1: SEM photograph of formulation F5 
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In Vitro Drug Release Studies 
The in vitro performance of LP microspheres showed prolonged and 
sustained release of LP. The results of the in vitro dissolution studies 
of formulations F1 to F5 are shown in Table 5.  
The study indicated that the amount of drug release decreases with 
an increase in the polymer concentration. The formulations F1 
showed a maximum of 98.84% and F5 showed a maximum of 
64.98% cumulative drug release. 
 
Table 4: In Vitro Drug Release Studies of all the formulations. 
Time(hrs) F1 F2 F3 F4 F5 
1 36.41±0.89 24.32±3.09 14.6±0.9 9.64±0.76 7.44±.045 
2 45.29±1.54 31.1±2.09 22.28±1.11 21.22±1.86 14.84±1.97 
3 59.23±2.09 39.06±.045 28.24±1.54 23.71±3.09 17.49±0.98 
4 67.38±1.97 45.06±0.78 32.52±.0.93 30.04±0.88 23.49±1.48 
6 73.07±1.32 57.82±0.98 38.48±1.34 56.12±1.97 29.52±2.13 
8 86.61±2.45 73.76±3.54 60.92±3.31 63.71±2.65 52.82±1.09 
10 93.53±3.08 84.92±0.59 72±0.09 70.43±3.07 59.22±3.09 
12 98.84±3.67 93.68±2.99 78.92±3.09 72.56±2.09 64.98±1.29 
 
Release kinetics 
Dissolution data of the all formulations were fitted in to different 
mathematic models (Zero order, First order, Higuchi and Peppas) in 
order to predict the kinetics of drug release rate.  
The model with high regression coefficient value (R2
By comparing the coefficient of determination (r2), it was found that 
formulations F1 and F4 followed first order kinetics where F2, F3 
and F5 followed Zero Order kinetics. Except F1 all the other 
formulations followed Non - Fickian transport. This can be 
attributed to the facts that as the polymer ratio increased resulted in 
the increase in diffusion path and Sigmoidal Pattern (Where drug is 
more distributed towards the core of the matrix) was another factor 
which resulted in Zero order release.  
) was chosen as 
the most appropriate model.  
 
Table 5: Kinetic Models applied and the R2
Formulation 
 values for different microsphere formulations 
Zero order R First order R2 Higuchi R2 Peppas R2 n values 2 
F1 0.8456 0.9231 0.9854 0.9888 0.4118 
F2 0.9629 0.0.9474 0.9846 0.9841 0.5658 
F3 0.9772 0.0.9664 0.9431 0.9743 0.6874 
F4 0.9438 0.973 0.9406 0.9726 0.8379 
F5 0.9779 0.9695 0.908 0.9803 0.8843 
 
CONCLUSION 
The concept of formulating microspheres containing Losartan 
Potassium offers a suitable, practical approach to achieve a 
prolonged therapeutic effect by continuously releasing the medicament 
over extended period of time. Losartan Potassium microspheres were 
successfully prepared by solvent evaporation technique using the 
different concentration of polymer and drug ratios. Among the various 
methods reported for the preparation of microspheres, this method was 
chosen as it is a simple and novel method. 
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